Source link : https://www.newshealth.biz/health-news/europe-oks-marketing-of-hemophilia-a-drug/
The European Commission (EC) has granted marketing authorization for Altuvoct (efanesoctocog alfa, Sobi) to treat and prevent bleeds and for perioperative prophylaxis in hemophilia A for all age groups and disease severities. The EC also endorsed a recommendation by the European Medicines Agency (EMA) to support Altuvoct’s retention of orphan drug designation, granting a 10-year […]
Author : News Health
Publish date : 2024-06-21 15:27:17
Copyright for syndicated content belongs to the linked Source.
Categories